BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17548897)

  • 1. Incretin agents in type 2 diabetes.
    Ross SA; Ekoé JM
    Can Fam Physician; 2010 Jul; 56(7):639-48. PubMed ID: 20631270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin effects on β-cell function, replication, and mass: the human perspective.
    Garber AJ
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S258-63. PubMed ID: 21525465
    [No Abstract]   [Full Text] [Related]  

  • 3. What are incretins, and how will they influence the management of type 2 diabetes?
    Blonde L; Rosenstock J; Triplitt C
    J Manag Care Pharm; 2006 Sep; 12(7 Suppl A):S2-12; quiz S14-6. PubMed ID: 16981805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut hormones and related concepts.
    Bloomgarden ZT
    Diabetes Care; 2006 Oct; 29(10):2319-24. PubMed ID: 17003315
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
    Amori RE; Lau J; Pittas AG
    JAMA; 2007 Jul; 298(2):194-206. PubMed ID: 17622601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatments for patients with type 2 diabetes.
    Haines ST
    Diabetes Educ; 2007; 33 Suppl 5():105S-10S. PubMed ID: 17548897
    [No Abstract]   [Full Text] [Related]  

  • 7. GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
    Ahrén B
    Curr Diab Rep; 2007 Oct; 7(5):340-7. PubMed ID: 18173966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
    Drucker DJ; Nauck MA
    Lancet; 2006 Nov; 368(9548):1696-705. PubMed ID: 17098089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do different GLP-1 mimetics differ in their actions?
    Choukem SP; Gautier JF
    Curr Diab Rep; 2006 Nov; 6(5):365-72. PubMed ID: 17076997
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.